(Q35042467)

6 August 2017

OMICS-based personalized oncology: if it is worth doing, it is worth doing well! (English)

1 reference

6 August 2017

Daniel F Hayes

1

1 reference

PubMed ID

24228698

6 August 2017

language of work or name

English

0 references

publication date

17 October 2013

1 reference

6 August 2017

1 reference

6 August 2017

11

1 reference

6 August 2017

221

1 reference

https://scigraph.springernature.com/pub.10.1186/1741-7015-11-221

6 August 2017

0 references

cites work

Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3876724

Criteria for the use of omics-based predictors in clinical trials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3876724

8 July 2018

Breaking a vicious cycle

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3876724

Activating HER2 mutations in HER2 gene amplification negative breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3876724

Publication of tumor marker research results: the necessity for complete and transparent reporting

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3876724

Randomized phase II trial designs with biomarkers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3876724

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version).

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3876724

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3876724

Use of archived specimens in evaluation of prognostic and predictive biomarkers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3876724

The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3876724

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3876724

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3876724

Clinical trial designs for predictive marker validation in cancer treatment trials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3876724

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3876724

Personalizing cancer care: American Society of Clinical Oncology presidential address 2009

25 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24228698

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Biospecimen reporting for improved study quality (BRISQ)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24228698

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Reporting recommendations for tumor marker prognostic studies

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24228698

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1741-7015-11-221

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

PubMed ID

24228698